|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| C07K 16/18 | |||
| C07K 16/46 | |||
| A61K 39/395 | |||
| C12N 15/13 | |||
| G01N 33/577 | |||
| A61P 37/06 | |||
| A61P 19/02 |
| (11) | Number of the document | 1558647 |
| (13) | Kind of document | T |
| (96) | European patent application number | 03776676.3 |
| Date of filing the European patent application | 2003-11-07 | |
| (97) | Date of publication of the European application | 2005-08-03 |
| (45) | Date of publication and mention of the grant of the patent | 2015-06-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/BE2003/000192 |
| Date | 2003-11-07 |
| (87) | Number | WO 2004/041862 |
| Date | 2004-05-21 |
| (30) | Number | Date | Country code |
| 425073 P | 2002-11-08 | US | |
| 425063 P | 2002-11-08 | US | |
| 03447005 | 2003-01-10 | EP | |
| PCT/EP03/06581 | 2003-06-23 | WO | |
| PCT/EP03/07313 | 2003-07-08 | WO |
| (72) |
SILENCE, Karen, BE
LAUWEREYS, Marc, BE
DE HAARD, Hans, NL
|
| (73) |
Ablynx N.V.,
Technologiepark 21, 9052 Ghent-Zwijnaarde,
BE
|
| (54) | SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST TUMOUR NECROSIS FACTOR-ALPHA AND USES THEREFOR |
| SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST TUMOUR NECROSIS FACTOR-ALPHA AND USES THEREFOR |